The enhancement of mucosal CD4+ T cells producing IL-17 is important for the development of a protective vaccine against TB as well as the production of IFN-γ CD4+ T cells, which have been previously demonstrated to be of high importance against TB in humans [55,56]. Here, CD4 is linked to tuberculosis.